comparemela.com

Latest Breaking News On - Cleveland clinic mellen center - Page 6 : comparemela.com

Johnson & Johnson COVID vaccine and Guillain-Barré: Everything to know

Johnson & Johnson COVID vaccine and Guillain-Barré: Everything to know
usatoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usatoday.com Daily Mail and Mail on Sunday newspapers.

COVID-19 vaccine by J&J comes with rare nerve syndrome warning Here s what to know about it

COVID-19 vaccine by J&J comes with rare nerve syndrome warning Here s what to know about it
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Newly Approved MS Drug Ponvory Reduces Fatigue, Study Shows

Janssen If fatigue is part of your life with relapsing multiple sclerosis (RMS) and it likely is a new drug may provide some relief. JAMA Neurology, ponesimod (marketed under the brand name Ponvory) was found to reduce fatigue significantly better than teriflunomide (Aubagio), another commonly used drug in the treatment of RMS. In addition, the drug was found to surpass teriflunomide in lowering the MS relapse rate in study participants and in reducing the risk of new or enlarging lesions seen on magnetic resonance imaging (MRI) scans. Ponesimod was approved by the U.S. Food and Drug Administration (FDA) in March 2021 for use in adults with various types of RMS, including clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary-progressive MS (SPMS).

Telemedicine for MS Care: Two Thumbs Up

Medically Reviewed You’ll need to be able to place your device on a stationary surface to show your doctor how you’re walking or moving other body parts. iStock When the COVID-19 pandemic first started sweeping through the United States in the spring of 2020, visits to doctors’ offices and medical clinics ground to a screeching halt, with patients staying home to avoid getting the virus. But people with chronic conditions such as multiple sclerosis (MS), as well as those with acute medical problems other than COVID-19, still needed access to healthcare, and in short order, telemedicine began to emerge as an alternative to in-person care.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.